Lisa Altman

Lisa Altman | Director of Strategy, Innovation and Improvement, South Eastern Sydney LHD

Working across the three pillars of her South Eastern Sydney LHD directorate, Lisa Altman oversees everything from the development of real-time patient data dashboards for clinicians to the investigation and implementation of research-driven clinical improvements to improve patient outcomes. She also represents the South Eastern Sydney LHD in the ongoing development of the Randwick Health and Innovation Precinct. It’s that aspect of her role that sees her working closely with the Tyree IHealthE team.

Why is Tyree IHealthE important to the South Eastern Sydney LHD?

There are two really clear reasons. The first is that we are partners in the Randwick Health and Innovation Precinct and, for me, it’s crucial to be collaborating with Tyree IHealthE because they sit at the intersection of the health and the academic spaces. The second reason is that tele-clinical care or TCC, which has come out of a partnership between the Tyree IHealthE biomedical engineering team and South Eastern Sydney LHD clinicians, is what we're looking at as a foundational platform for dealing with some of the biggest challenges we face now around the growing demands of chronic disease and an ageing population.

What is the value of the TCC platform to South Eastern Sydney LHD?

The exciting thing about TCC from my perspective is that we have had the opportunity to jointly develop the solution, and jointly develop the roadmap. That makes it much more valuable than any off-the-shelf products we could get. Commercial vendors might pay lip service to tailoring and customising the product, but it's nothing like the really collaborative partnership that we've had.

What are the challenges ahead for the further implementation and commercialisation of the TCC product?

One of the silver linings of the COVID-19 experience is that we've been able to test at scale. We've now cleared a lot of the hurdles and streamlined the process and, in collaboration with Tyree IHealthE, we’ve significantly improved the product. Now we’re thinking about how we can take this from being a product used for COVID-19 in the acute sense, to COVID-19 as an endemic disease, alongside other chronic diseases. Using the TCC platform in that way will require further changes, particularly to the back-end and the reporting and performance metrics. We're having those conversations now.

A very big thank you to Lisa for taking the time to talk with us about South Eastern Sydney LHD and how it works with Tyree IHealthE.